AxialBridge Announces Collaboration Leveraging AI for Next-Generation Clinical Trial Technologies
AxialBridge Announces Collaboration Leveraging AI for Next-Generation Clinical Trial Technologies
Knowde is excited to announce its partnership with Husch Blackwell to assist companies with psychedelic clinical trials & DEA licensing support in the United States.
Knowde is excited to announce its partnership with Husch Blackwell to assist companies with psychedelic clinical trials & DEA licensing support in the United States.
Knowde Group Announces Successful Site Support Post Health Canada Non-Compliance Inspection
We are excited to announce the successful completion of our regulatory and site support post Health Canada inspection for Remedy Institute, which is a research site conducting phase 2 MDMA clinical trials in Canada.